ACG 2024
Philadelphia, PA, 25 - 30 Oct 2024
We are looking forward to exhibiting exhibiting at this year’s ACG 2024 conference. This event provides attendees in-depth discussions on a broad range of cutting-edge topics in GI, hepatology, and endoscopy, along with the opportunity to network, share experiences, and see the latest advances in gastrointestinal technology and therapeutics.
We will be presenting these posters:
- Introducing the VOC Atlas: A List of Microbiome-Associated VOCs for Breath-Based Biomarker Discovery
- Targeted Breath Biopsy Profiling of Induced Biomarkers Unveils a Metabolic Adaptation in Cirrhosis Toward Alcohol Production
- Analyzing Metabolic Responses to a Standardized Meal Challenge Using Exhaled Breath
- Development and Validation of a Portable Device for At-Home Hydrogen and Methane Breath Testing
If you are interested in discussing how to incorporate breath analysis into your gastroenterology workflow please get in touch to meet with us at the conference at Booth 413.
Meet the Team:
Dr Huw Davies has over 30 years experience working with novel technologies that enable the diagnosis and treatment of major human diseases. In his current role, Huw leads a global commercial team responsible for growing Owlstone Medical’s Breath Biopsy® collaborations and service business with leading pharmaceutical companies and academic partners to identify and deploy novel non-invasive breath biomarkers for precision medicine and disease diagnosis.
Amine Khider
Amine is a Business Development Executive at Owlstone Medical, where he works with and supports researchers across the U.S. and Canada to help them explore and utilize breath as a biomarker matrix to advance their research. Holding a Master’s in Pharmaceutical Sciences and a PharmD, he combines robust academic knowledge with practical experience gained as a Scientific Sales Specialist at Merck Life Sciences, where he refined his expertise in sales management.
